These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30867092)

  • 1. Should anticoagulants be prescribed with Aspirin?
    Simonson W
    Geriatr Nurs; 2019; 40(2):212-213. PubMed ID: 30867092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long term aspirin in stable coronary disease with an indication for anticoagulation: is it reasonable?].
    Lister K; Louis Simonet M
    Rev Med Suisse; 2015 Oct; 11(490):1904, 1906-8. PubMed ID: 26665660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulation alone or in combination with aspirin: risks and benefits.
    Hafner J; de Moerloose P; Bounameaux H
    Vasa; 1996; 25(1):1-12. PubMed ID: 8851260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
    Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
    Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
    Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should patients on long-term warfarin take aspirin for heart disease?
    Madhwal S; Lincoff AM; Rolston DD
    Cleve Clin J Med; 2008 Mar; 75(3):206-8. PubMed ID: 18383929
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome.
    Ahmad T; Davies R; Alagona P
    J Fam Pract; 2017 Feb; 66(2 Suppl):. PubMed ID: 29095443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis.
    Fortuni F; Ferlini M; Leonardi S; Angelini F; Crimi G; Somaschini A; Cornara S; Potenza A; De Servi S; Oltrona Visconti L; De Ferrari GM
    Int J Cardiol; 2018 Dec; 273():80-87. PubMed ID: 30115419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
    Tay KH; Lane DA; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):955-7. PubMed ID: 19132214
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple therapy: triple safety or triple danger?
    Dewilde W; Breet N; Ten Berg J
    Am J Cardiol; 2010 Feb; 105(4):579. PubMed ID: 20152257
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of bleeding with concomitant use of oral anticoagulants and aspirin: A systematic review and meta-analysis.
    Ghule P; Panic J; Malone DC
    Am J Health Syst Pharm; 2024 Jun; 81(12):494-508. PubMed ID: 38263263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 16. Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: a jump with a weak parachute?
    Galli M; Andreotti F; Savarese G; D'Amario D; Vergallo R; Della Bona R; Calò L; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):55-56. PubMed ID: 30289484
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiaggregation: aspirin].
    Eichenberger A; Pontiggia L; Beer JH
    Ther Umsch; 2003 Jan; 60(1):15-8. PubMed ID: 12638472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Friesen M
    Ann Pharmacother; 2008 Oct; 42(10):1521; author reply 1521. PubMed ID: 18765833
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleeding complications related to aspirin dose.
    Laine L; McQuaid K
    Am J Cardiol; 2005 Oct; 96(7):1035-6. PubMed ID: 16188542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.